Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

<p>5hmC patterns change at different states and subgroups of prostate cancer. <b>A,</b> Unsupervised visualization of global 5hmC patterns for different prostate cancer states using principal component analysis for gene body counts of the top 10% variable protein coding genes. Beni...

保存先:

書誌詳細
第一著者:	Martin Sjöström (14845882) (author)
その他の著者:	Shuang G. Zhao (12227671) (author), Samuel Levy (14960811) (author), Meng Zhang (14960814) (author), Yuhong Ning (279537) (author), Raunak Shrestha (14949693) (author), Arian Lundberg (14960817) (author), Cameron Herberts (14960820) (author), Adam Foye (14960823) (author), Rahul Aggarwal (14960826) (author), Junjie T. Hua (14960829) (author), Haolong Li (1532230) (author), Anna Bergamaschi (14960832) (author), Corinne Maurice-Dror (14960835) (author), Ashutosh Maheshwari (14960838) (author), Sujun Chen (3553841) (author), Sarah W.S. Ng (14960841) (author), Wenbin Ye (14960844) (author), Jessica Petricca (14960847) (author), Michael Fraser (522709) (author), Lisa Chesner (14960850) (author), Marc D. Perry (14960853) (author), Thaidy Moreno-Rodriguez (14960856) (author), William S. Chen (14960859) (author), Joshi J. Alumkal (14950518) (author), Jonathan Chou (14957015) (author), Alicia K. Morgans (5600567) (author), Tomasz M. Beer (14960862) (author), George V. Thomas (13187926) (author), Martin Gleave (146446) (author), Paul Lloyd (14960865) (author), Tierney Phillips (4664332) (author), Erin McCarthy (14960868) (author), Michael C. Haffner (14960871) (author), Amina Zoubeidi (14960874) (author), Matti Annala (219688) (author), Robert E. Reiter (14960877) (author), Matthew B. Rettig (14960880) (author), Owen N. Witte (14960883) (author), Lawrence Fong (14960886) (author), Rohit Bose (14960889) (author), Franklin W. Huang (10726678) (author), Jianhua Luo (14960892) (author), Anders Bjartell (199682) (author), Joshua M. Lang (12227674) (author), Nupam P. Mahajan (14960895) (author), Primo N. Lara (13009812) (author), Christopher P. Evans (14960898) (author), Phuoc T. Tran (14960901) (author), Edwin M. Posadas (14960904) (author), Chuan He (178952) (author), Xiao-Long Cui (2020402) (author), Jiaoti Huang (88989) (author), Wilbert Zwart (14960907) (author), Luke A. Gilbert (5513207) (author), Christopher A. Maher (14960910) (author), Paul C. Boutros (14954698) (author), Kim N. Chi (14960913) (author), Alan Ashworth (14957030) (author), Eric J. Small (14960916) (author), Housheng H. He (14960919) (author), Alexander W. Wyatt (14960922) (author), David A. Quigley (14957012) (author), Felix Y. Feng (14845891) (author)
出版事項:	2025
主題:	Cancer Cancer Risk Factors Molecular and Cellular Biology Methods and Technology Epigenetics Epigenomics Genitourinary Cancers Prostate cancer Liquid Biopsy
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Figure 5 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
著者:: Martin Sjöström (14845882)
出版事項: (2025)

Figure 1 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
著者:: Martin Sjöström (14845882)
出版事項: (2025)

Figure 3 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
著者:: Martin Sjöström (14845882)
出版事項: (2025)

Figure 4 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
著者:: Martin Sjöström (14845882)
出版事項: (2025)

Figure 6 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
著者:: Martin Sjöström (14845882)
出版事項: (2025)

Figure 7 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
著者:: Martin Sjöström (14845882)
出版事項: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
著者:: Martin Sjöström (14845882)
出版事項: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
著者:: Martin Sjöström (14845882)
出版事項: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
著者:: Martin Sjöström (14845882)
出版事項: (2025)

Supplementary Figure 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
著者:: Alex Chehrazi-Raffle (17079582)
出版事項: (2025)

Supplementary Data 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
著者:: Alex Chehrazi-Raffle (17079582)
出版事項: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
著者:: Sofie H. Tolmeijer (15313251)
出版事項: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
著者:: Sofie H. Tolmeijer (15313251)
出版事項: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
著者:: Sofie H. Tolmeijer (15313251)
出版事項: (2025)

Supplementary Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations
著者:: John Gallon (15096459)
出版事項: (2025)

Supplementary Data 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
著者:: Arian Lundberg (14960817)
出版事項: (2025)

Supplementary Data 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
著者:: Arian Lundberg (14960817)
出版事項: (2025)

Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
著者:: Arian Lundberg (14960817)
出版事項: (2025)

Supplementary Table 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
著者:: Arian Lundberg (14960817)
出版事項: (2025)

Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
著者:: Arian Lundberg (14960817)
出版事項: (2025)

Supplementary Data 1 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
著者:: Hong Qiu (14963144)
出版事項: (2025)

Supplementary Data 2 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
著者:: Hong Qiu (14963144)
出版事項: (2025)

Supplementary Table S1 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
著者:: Rongxin Zhang (15293341)
出版事項: (2025)

Supplementary Table S2 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
著者:: Rongxin Zhang (15293341)
出版事項: (2025)

Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
著者:: Abdullah A. Osman (15056323)
出版事項: (2025)

Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
著者:: Abdullah A. Osman (15056323)
出版事項: (2025)

Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
著者:: Abdullah A. Osman (15056323)
出版事項: (2025)

Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
著者:: Abdullah A. Osman (15056323)
出版事項: (2025)

Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
著者:: Abdullah A. Osman (15056323)
出版事項: (2025)

Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
著者:: Abdullah A. Osman (15056323)
出版事項: (2025)

Supplementary Tables 1 from Proteostasis Modulation in Germline Missense von Hippel Lindau Disease
著者:: Prashant Chittiboina (15367044)
出版事項: (2025)

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
著者:: Emil Christensen (15054394)
出版事項: (2025)

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
著者:: Emil Christensen (15054394)
出版事項: (2025)

Figure 5 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
著者:: James R. Larkin (14936324)
出版事項: (2025)

Supplementary Table S5 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Figure S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
著者:: Kala Visvanathan (14952973)
出版事項: (2025)

Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
著者:: Dipika R. Mohan (15011204)
出版事項: (2025)

Supplementary Table S1 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Table S3 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_8p7gbqjn3mlb9a5sqjdq2sfcru